“Substantial” Device Effectiveness Proposed As Coverage Decision Category
This article was originally published in The Gray Sheet
Executive Summary
CMS will allow the Medicare Coverage Advisory Committee to designate a new effectiveness category for devices showing a "substantial clinical benefit" over existing technologies, Acting Chief Clinical Officer Sean Tunis indicated Sept. 25
You may also be interested in...
Draft Guidance On NCD MCAC Referral Has Ongoing Comment Period
Industry reps plan to hold a conference call within the next several weeks to discuss a 1CMS draft guidance stipulating criteria for when national coverage determinations should be referred for external review or to the Medicare Coverage Advisory Committee
Draft Guidance On NCD MCAC Referral Has Ongoing Comment Period
Industry reps plan to hold a conference call within the next several weeks to discuss a 1CMS draft guidance stipulating criteria for when national coverage determinations should be referred for external review or to the Medicare Coverage Advisory Committee
CMS on deep-brain stimulation
National coverage determination for Parkinson's disease treatment expected by year-end, the agency states Nov. 4. The Medicare Coverage Advisory Committee executive committee previously voted for an NCD for bilateral deep-brain stimulation in a well-defined set of Parkinson's patients (1"The Gray Sheet" Sept. 30, 2002, p. 11)...